Moderna Starts Tests with Bundibugyo Ebola Vaccine, Outbreak in DR Congo Continues

TL;DR AI-generated Moderna has begun a Phase 1 study of an mRNA-based vaccine against the Bundibugyo Ebola virus. The Democratic Republic of Congo continues to experience its second-fastest Ebola outbreak, with 3,802 registered cases and 1,707 deaths.